Safety Profile of Subjects Treated to Very Low Low-Density Lipoprotein Cholesterol Levels (<30 mg/dl) With Rosuvastatin 20 mg Daily (from JUPITER) - Everett, Brendan M.; Mora, Samia; Glynn, Robert J.; MacFadyen, Jean; Ridker, Paul M. (The American journal of cardiology, 2014)
Keywords: Aged; Apolipoproteins; Cardiovascular; Cholesterol; Cholesterol, LDL - blood; Diabetes; Diabetes Mellitus, Type 2 - epidemiology; Double-Blind Method; Female; Fluorobenzenes - therapeutic use; Hematuria - epidemiology; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Insomnia; Kinases; Liver Diseases - epidemiology; Low density lipoprotein; Male; Metabolism; Middle Aged; Odds Ratio; Proportional Hazards Models; Pyrimidines - therapeutic use; Rosuvastatin Calcium; Sleep Initiation and Maintenance Disorders - epidemiology; Statins; Stroke; Sulfonamides - therapeutic use; Treatment Outcome; Triglycerides